Site US10021 — Madison, Wisconsin

Site US10021 is a clinical research site located in Madison, Wisconsin, United States 53792.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Site US10021 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Prostate Cancer.

Sponsors: Astellas Pharma Global Development, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US10021?

Site US10021 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US10021 conducted?

Site US10021 has 1 clinical trials on record, with 1 currently active. Their work covers Prostate Cancer.

Is Site US10021 accredited by Crixeo Health?

Site US10021 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US10021?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.